Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // July 14th, 2011 // 7:31 am
Hello, everyone, and apologies for the late start. We are readying an interesting item for later this morning and so have been scrambling to attend to the usual routine. Nonetheless, we are fortified by our usual cup of stimulation and are proud to present you with a few tidbits from around your world. Meanwhile, stay tuned for that aforementioned story. And have a great day…
Seattle Genetics Hodgkin’s Drug Wins FDA Panel Backing (The Street)
Cancer Drugmakers Are Hot Takeover Targets (Reuters)
Hormone Meds May Boost Life Expectancy For Prostate Cancer Patients (Bloomberg News)
Most Pharma Execs See More M&A (Associated Press)
Transcept Insomnia Pill Fails To Win Approval (Bloomberg News)
Boerhinger Plant Closure Eliminates 100 Jobs (The Chicago Tribune)
Prescriptions For Glaxo’s Advair Are Slowing (Pharma Times)
Pfizer Strikes Deal For Stem Cells With Roslin Cells (Pharma Times)
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Boehringer Ingelheim, Hormone Treatment, Insomnia, jobs, M&A, Medicis Pharmaceuticals, Pfizer, Pollution, Prostate Cancer, Rosin Cells, Seattle Genetics, Sioux Pharma, Sleeping Pills, Stem Cells, Transcept Pharmaceuticals, Wastewater